OpenCell Technologies

OpenCell Technologies is a leading innovator developing a cutting-edge, continuous, scalable, non-viral, cell-type agnostic soft-poration transfection technology. Our breakthrough platform enables the efficient and continuous delivery of large payloads into challenging cell types, advancing the frontiers of cell engineering in biopharmaceuticals and cell and gene therapies. With precise control at the single-cell level and high throughput, our OpenCell™ technology accelerates scientific discovery and enhances the efficacy, affordability, and scalability of current cell therapies. We empower researchers and clinicians to achieve significant advancements in biomedical science and clinical practice.